That's the entire point of my post, since SOC changed and...

That's the entire point of my post, since SOC changed and putting people onto ventilators was either deemed no longer necessary or delayed and used on only severe or near-death cases, why wasn't this sort of analysis commented on by SI? Surely the time difference between the early RemL cohort from hospitalisation to ventilation (and therefore RemL dosing) was significantly different by the time that the 3rd review occurred.

I expect that dexamethasone's greatest effect is to limit lung damage (through reduction in inflammation) prior to ventilation and dosing with Rem-L.

What I'd be interested in is results from Rem-L dosing upon admission to ICU, I expect they will be very strong, though obviously a larger cohort will need to be enrolled.